Autism Spectrum Disorder Management Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028


#14624

Future Market Insights

$ 5000

Global Autism Spectrum Disorder Management Market: Overview

The reports of autism in children have increased severely in recent times. According to the Centers for Disease Control and Prevention (CDC), 1 in 59 children were affected by this neurological disorder in the U.S. alone. The increasing awareness about autism among global population and various initiatives by several governments to control its prevalence are boosting the growth of the global autism spectrum disorder management market. The imminent approvals of several off-label treatment therapies by the U.S. FDA are likely to support this market in the near future.

Patients of autism spectrum disorder need more healthcare resource and proper management. However, these healthcare practices, including hospital visits, medication, and hospitalization, are highly expensive. This, in turn, has prompted market players to look for advanced yet reasonably-priced healthcare solutions, such as managed care, to meet the needs for autism patients.

Although the growth trajectory of the autism spectrum disorder management market looks pretty smooth, there are several tough challenges that market players are facing while serving customers. The most prominent among them are:

  • Diagnostic Approach: The first challenge, healthcare management providers face, is which approach to choose for diagnosis and how to include the technology in primary evaluation of patients.  Although there are a number of diagnostic approaches present, the lack of access to latest technologies keeps them from identifying the best approach.
  • Lack of Access in Rural Area: Often, there is no autism diagnosis and treatment centers in rural areas, owing to which autism spectrum disorder management services could not reach needy patients. However, tele-health has surfaced as a support practice for autism spectrum disorder management in these areas.

Autism spectrum is a neurological disorder. The autism spectrum affects the development and growth of the brain which remain lifelong. The autism spectrum disorder is identified in primary childhood stage. Autism spectrum affects a person in many ways, such as behaviours changes, communication problem in daily lifecycles, lack of interaction in society and many others also. The cause of autism spectrum disorder is not known to the research team or scientists, who are working to find sources of autism spectrum disorder, yet the prediction, and recent research studies have found that the cause may be an outcome of genetic disorder. The person who is affected with autism spectrum has major issues to live his/her normal life such as normal non-verbal communication, depression or anxiety and many others problem. Almost all children with autism spectrum disorder fall under age-group ranging from 2 to 3 year, and show specific indications, which can be diagnosed in early age of 18 months.

Autism Spectrum Disorder Management Market: Drivers and Restraints

Autism spectrum disorder management market will witness a significant growth over the forecast period. According to the CDC (Centers for Disease Control and Prevention), 1 in 68 children in U.S is affected with autism spectrum disorder, and each year around 50,000 children lose their basic education as they are affected with autism spectrum disorder. Autism spectrum disorder is more shown by boys then that of girls, as per CDC it’s about 4.5 more in boys then girls.  The major problem associated with autism spectrum disorder are speaking problem, communication problem and others. Research institute and players are working on find the sources and simple treatment process to provide a better life to the people affected with autism spectrum disorder.  As of the hindrance the lack of awareness and improper diagnosis lead to affect the market.    

Autism Spectrum Disorder Management Market: Segmentation

Segmentation of autism spectrum disorder management based on:

Autism spectrum disorder management based on Treatment Type:

Dietary Approaches

Medication

  • Risperidone
  • Aripiprazole
  • Clozapine
  • Haloperidol
  • Sertraline
  • Methylphenidate
  • Venlafaxine
  • Fluoxetine
  • Others

Communication and Behavior Approaches

Others

Autism spectrum disorder management based on Channel:

  • Hospitals
  • Education Counsellor Center
  • Others

Autism Spectrum Disorder Management Market: Overview

Autism spectrum disorder is major problem in majority of the children, as autism spectrum disorder is not diagnosis easily and the treatment process is also based on various factors such as the society, friend circles, and other special attention from others, therefore the treatment process is also known as management for autism spectrum disorder suffering person. As per CDC (Centers for Disease Control and Prevention) the diagnosis has two step process in child, such as general screening for the development in the child at 18 to 24 month. The second stage is based on the assessment by the pediatrician doctor for the particular child who may be or may not be suffering from autism spectrum disorder. Pediatrician assessment includes various psychological test and other abilities to perform the task and daily lifestyle activity. Majority of the patients or child which are suffering from autism spectrum disorder are managed by providing medication and other lifestyle support.         

Autism Spectrum Disorder Management Market: Region-wise Outlook

Geographically, Autism spectrum disorder management market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. North America is the major market for autism spectrum disorder management market, according to CDC U.S has maximum number of patients suffering from autism spectrum disorder. Europe also shows growth potential, as local authorities are providing funds for the education and other medication support. Asia Pacific also shows a significant growth in the market of autism spectrum disorder management as the awareness is increasing in the region by various NGO activities and the number of patients which are suffering is also high, according to Autism Spectrum Australia that around 230,000 population of Australia is suffering from autism spectrum disorders.    

Autism Spectrum Disorder Management Market: Key Players

Some of the players in autism spectrum disorder management market include: Novartis AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., ALLERGAN, Celgene Corporation, GlaxoSmithKline Plc and Exelon Corporation.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

The report provides the following information:

  • Tailwinds and headwinds molding the market’s trajectory
  • Market segments based on products, technology, and applications
  • Prospects of each segment
  • Overall current and possible future size of the market
  • Growth pace of the market
  • Competitive landscape and key players’ strategies

The main aim of the report is to:

  • Enable key stakeholder’s in the market bet right on it
  • Understand the opportunities and pitfalls awaiting them
  • Assess the overall growth scope in the near term
  • Strategize effectively with respect to production and distribution

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.